Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Myriad Genetics Inc (NQ: MYGN )

25.95 USD -0.16 (-0.63%)
Streaming Delayed Price Updated: 12:02 PM EDT, May 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Myriad Genetics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
70 Biggest Movers From Yesterday
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a ... 
Tags KAR CZR Benzinga
From Benzinga
Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference
From GlobeNewswire News Releases
Recap: Myriad Genetics Q3 Earnings
Shares of Myriad Genetics (NASDAQ:MYGN) remained flat in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Benzinga BZI/Recaps MYGN
From Benzinga
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
From GlobeNewswire News Releases
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp
From GlobeNewswire News Releases
Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor Day
Company continues to focus on expanding its reach and organic growth, expense control, and laying foundation for advancing leadership position in genetic testing and precision medicine 
From GlobeNewswire News Releases
Earnings Scheduled For May 3, 2021
Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 ... 
Tags UAN CBT NSP
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
Tags EXAS INCY ADCT
From Benzinga
Myriad Genetics's Earnings Outlook
Myriad Genetics (NASDAQ:MYGN) unveils its next round of earnings this Monday, May 03. Here is Benzinga's everything-that-matters guide ... 
Tags Market News BZI/EP Benzinga
From Benzinga
Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment
New poll shows 83% of people with depression agree life would be easier if others could understand their depression 
From GlobeNewswire News Releases
Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021
From GlobeNewswire News Releases
Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences
From GlobeNewswire News Releases
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.
Brooklyn ImmunoTherapeutics announces the appointment of Dennis H. Langer to the Company’s Board as an independent Director 
From Business Wire News Releases
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks Offerings Biotech
From Benzinga
Sera Prognostics Appoints Robert G. Harrison as Chief Information Officer
From GlobeNewswire News Releases
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
From GlobeNewswire News Releases
MYRIAD GENETICS ALERT: Bragar Eagel & Squire, P.C. Announces the Shareholder Class Action Against Myriad Genetics, Inc. Survives Motion to Dismiss and Encourages Long-term Investors to Contact the Fir
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that the Shareholder Class Action Against Myriad Genetics, Inc. (NASDAQ: MYGN) has survived the motions to... 
From Business Wire News Releases
The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech SWAV VINC
From Benzinga
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MYGN LHDX Earnings
From Benzinga
Myriad Genetics Inc (MYGN) Q2 2021 Earnings Call Transcript
MYGN earnings call for the period ending December 31, 2020. 
Tags Market News MYGN
From Motley Fool
Recap: Myriad Genetics Q2 Earnings
Shares of Myriad Genetics (NASDAQ:MYGN) were unchanged inafter-market trading after the company reported Q2 results. Quarterly ... 
Tags Benzinga BZI/Recaps Earnings
From Benzinga
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
From GlobeNewswire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings MYGN ANNX
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags CMLS Market News ESPR
From Benzinga
A Preview Of Myriad Genetics's Earnings
Myriad Genetics (NASDAQ:MYGN) will be releasing its next round of earnings this Tuesday, February 23. For all of the relevant ... 
Tags MYGN Earnings Benzinga
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags PODD SAGE HALO
From Benzinga
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
New talent and promotions span core businesses, transformation, IT, revenue cycle management, business development, marketing, legal 
From GlobeNewswire News Releases
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
From GlobeNewswire News Releases
New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer
Results from second study cite Prolaris® as most clinically significant prognostic parameter of outcomes at time of diagnosis, identifying men who need aggressive hormonal treatment and those who can... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
83 84 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.